Tech Center 1600 • Art Units: 1641 1677 1678
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18412316 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | Non-Final OA | SONY GROUP CORPORATION |
| 18341906 | METHOD | Non-Final OA | Oxford Nanopore Technologies PLC |
| 17259601 | INTRAMOLECULAR KINETIC PROBES | Final Rejection | The Regents of the University of Michigan |
| 18480489 | TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 16523871 | POLYMERIC TANDEM DYES HAVING PENDANT NARROW EMISSION ACCEPTOR | Final Rejection | Becton, Dickinson and Company |
| 16487670 | BIOMATERIAL IMMOBILIZING METHOD AND USES THEREOF | Non-Final OA | MITSUBISHI GAS CHEMICAL COMPANY, INC. |
| 18339799 | METHOD FOR DETECTING AN ANALYTE OF INTEREST IN A SAMPLE | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 16931599 | HYPERCROSSLINKING WITH DIAMINE CROSSLINKERS | Final Rejection | Roche Diagnostics Operations, Inc. |
| 16599480 | SUPERPARAMAGNETIC AND HIGHLY POROUS POLYMER PARTICLES FOR DIAGNOSTIC APPLICATIONS | Final Rejection | Roche Diagnostics Operations, Inc. |
| 17265756 | COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI | Final Rejection | The University of Hong Kong |
| 18268034 | BLOOD-BASED PROTEIN BIOMARKER PANEL FOR EARLY AND ACCURATE DETECTION OF CANCER | Non-Final OA | The Brigham and Women`s Hospital, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy